What about side effects, safety, and beyond-weight-loss benefits
And this one honestly made me stop and reread the literature because it is, um, frankly, life changing if it, if it works for all endo patients now
Having overweight: Having extra weight can put more pressure on your colon
Three FDA-approved GLP-1 medications are eligible under the bridge program when used to reduce excess body weight and maintain weight reduction: Wegovy (semaglutide), available as a weekly injection or daily oral tablet, manufactured by Novo Nordisk Zepbound (tirzepatide), available in the KwikPen autoinjector format, manufactured by Eli Lilly Foundayo (orforglipron), the first non-peptide, small-molecule oral GLP-1 for weight loss, recently FDA-approved and manufactured by Eli Lilly Each of these medications works by mimicking the activity of glucagon-like peptide-1, a hormone that regulates appetite, fullness, and blood sugar
As weeks progress, your PlexusDx healthcare provider may recommend stepping up to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg based on your individual response and tolerability
Theyre often used alongside other weight loss treatments to improve overall results